Biodistribution, pharmacokinetics, and nuclear imaging studies of 111In-labeled rGel/BLyS fusion toxin in SCID mice bearing B cell lymphoma.
Identifieur interne : 001580 ( Main/Exploration ); précédent : 001579; suivant : 001581Biodistribution, pharmacokinetics, and nuclear imaging studies of 111In-labeled rGel/BLyS fusion toxin in SCID mice bearing B cell lymphoma.
Auteurs : RBID : pubmed:20686856English descriptors
- KwdEn :
- Animals, B-Cell Activating Factor (administration & dosage), B-Cell Activating Factor (blood), B-Cell Activating Factor (pharmacokinetics), Cell Death, Cell Line, Tumor, Chromatography, Thin Layer, Female, Humans, Indium Radioisotopes (administration & dosage), Indium Radioisotopes (blood), Indium Radioisotopes (pharmacokinetics), Injections, Intravenous, Lymphoma, B-Cell (blood), Lymphoma, B-Cell (pathology), Lymphoma, B-Cell (radiography), Lymphoma, B-Cell (radionuclide imaging), Mice, Mice, Inbred BALB C, Mice, SCID, Pentetic Acid (metabolism), Recombinant Fusion Proteins (administration & dosage), Recombinant Fusion Proteins (blood), Recombinant Fusion Proteins (pharmacokinetics), Ribosome Inactivating Proteins, Type 1 (administration & dosage), Ribosome Inactivating Proteins, Type 1 (blood), Ribosome Inactivating Proteins, Type 1 (pharmacokinetics), Staining and Labeling, Tissue Distribution, Tomography, Emission-Computed, Single-Photon, Tomography, X-Ray Computed.
- MESH :
- chemical , administration & dosage : B-Cell Activating Factor, Indium Radioisotopes, Recombinant Fusion Proteins, Ribosome Inactivating Proteins, Type 1.
- chemical , blood : B-Cell Activating Factor, Indium Radioisotopes, Recombinant Fusion Proteins, Ribosome Inactivating Proteins, Type 1.
- chemical , metabolism : Pentetic Acid.
- chemical , pharmacokinetics : B-Cell Activating Factor, Indium Radioisotopes, Recombinant Fusion Proteins, Ribosome Inactivating Proteins, Type 1.
- blood : Lymphoma, B-Cell.
- pathology : Lymphoma, B-Cell.
- radiography : Lymphoma, B-Cell.
- radionuclide imaging : Lymphoma, B-Cell.
- Animals, Cell Death, Cell Line, Tumor, Chromatography, Thin Layer, Female, Humans, Injections, Intravenous, Mice, Mice, Inbred BALB C, Mice, SCID, Staining and Labeling, Tissue Distribution, Tomography, Emission-Computed, Single-Photon, Tomography, X-Ray Computed.
Abstract
We examined the biodistribution and pharmacokinetics of (111)In-labeled rGel/BLyS, a gelonin toxin (rGel)-B lymphocyte stimulator (BLyS) fusion protein.
DOI: 10.1007/s11307-010-0391-0
PubMed: 20686856
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Biodistribution, pharmacokinetics, and nuclear imaging studies of 111In-labeled rGel/BLyS fusion toxin in SCID mice bearing B cell lymphoma.</title>
<author><name sortKey="Wen, Xiaoxia" uniqKey="Wen X">Xiaoxia Wen</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Experimental Diagnostic Imaging, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Experimental Diagnostic Imaging, The University of Texas M D Anderson Cancer Center, Houston, TX 77030</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lyu, Mi Ae" uniqKey="Lyu M">Mi-Ae Lyu</name>
</author>
<author><name sortKey="Zhang, Rui" uniqKey="Zhang R">Rui Zhang</name>
</author>
<author><name sortKey="Lu, Wei" uniqKey="Lu W">Wei Lu</name>
</author>
<author><name sortKey="Huang, Qian" uniqKey="Huang Q">Qian Huang</name>
</author>
<author><name sortKey="Liang, Dong" uniqKey="Liang D">Dong Liang</name>
</author>
<author><name sortKey="Rosenblum, Michael G" uniqKey="Rosenblum M">Michael G Rosenblum</name>
</author>
<author><name sortKey="Li, Chun" uniqKey="Li C">Chun Li</name>
</author>
</titleStmt>
<publicationStmt><date when="2011">2011</date>
<idno type="doi">10.1007/s11307-010-0391-0</idno>
<idno type="RBID">pubmed:20686856</idno>
<idno type="pmid">20686856</idno>
<idno type="wicri:Area/Main/Corpus">001824</idno>
<idno type="wicri:Area/Main/Curation">001824</idno>
<idno type="wicri:Area/Main/Exploration">001580</idno>
</publicationStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>B-Cell Activating Factor (administration & dosage)</term>
<term>B-Cell Activating Factor (blood)</term>
<term>B-Cell Activating Factor (pharmacokinetics)</term>
<term>Cell Death</term>
<term>Cell Line, Tumor</term>
<term>Chromatography, Thin Layer</term>
<term>Female</term>
<term>Humans</term>
<term>Indium Radioisotopes (administration & dosage)</term>
<term>Indium Radioisotopes (blood)</term>
<term>Indium Radioisotopes (pharmacokinetics)</term>
<term>Injections, Intravenous</term>
<term>Lymphoma, B-Cell (blood)</term>
<term>Lymphoma, B-Cell (pathology)</term>
<term>Lymphoma, B-Cell (radiography)</term>
<term>Lymphoma, B-Cell (radionuclide imaging)</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Mice, SCID</term>
<term>Pentetic Acid (metabolism)</term>
<term>Recombinant Fusion Proteins (administration & dosage)</term>
<term>Recombinant Fusion Proteins (blood)</term>
<term>Recombinant Fusion Proteins (pharmacokinetics)</term>
<term>Ribosome Inactivating Proteins, Type 1 (administration & dosage)</term>
<term>Ribosome Inactivating Proteins, Type 1 (blood)</term>
<term>Ribosome Inactivating Proteins, Type 1 (pharmacokinetics)</term>
<term>Staining and Labeling</term>
<term>Tissue Distribution</term>
<term>Tomography, Emission-Computed, Single-Photon</term>
<term>Tomography, X-Ray Computed</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>B-Cell Activating Factor</term>
<term>Indium Radioisotopes</term>
<term>Recombinant Fusion Proteins</term>
<term>Ribosome Inactivating Proteins, Type 1</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>B-Cell Activating Factor</term>
<term>Indium Radioisotopes</term>
<term>Recombinant Fusion Proteins</term>
<term>Ribosome Inactivating Proteins, Type 1</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Pentetic Acid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>B-Cell Activating Factor</term>
<term>Indium Radioisotopes</term>
<term>Recombinant Fusion Proteins</term>
<term>Ribosome Inactivating Proteins, Type 1</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Lymphoma, B-Cell</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lymphoma, B-Cell</term>
</keywords>
<keywords scheme="MESH" qualifier="radiography" xml:lang="en"><term>Lymphoma, B-Cell</term>
</keywords>
<keywords scheme="MESH" qualifier="radionuclide imaging" xml:lang="en"><term>Lymphoma, B-Cell</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Cell Death</term>
<term>Cell Line, Tumor</term>
<term>Chromatography, Thin Layer</term>
<term>Female</term>
<term>Humans</term>
<term>Injections, Intravenous</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Mice, SCID</term>
<term>Staining and Labeling</term>
<term>Tissue Distribution</term>
<term>Tomography, Emission-Computed, Single-Photon</term>
<term>Tomography, X-Ray Computed</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We examined the biodistribution and pharmacokinetics of (111)In-labeled rGel/BLyS, a gelonin toxin (rGel)-B lymphocyte stimulator (BLyS) fusion protein.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">20686856</PMID>
<DateCreated><Year>2011</Year>
<Month>07</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted><Year>2011</Year>
<Month>10</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised><Year>2014</Year>
<Month>04</Month>
<Day>08</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1860-2002</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>13</Volume>
<Issue>4</Issue>
<PubDate><Year>2011</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging</Title>
<ISOAbbreviation>Mol Imaging Biol</ISOAbbreviation>
</Journal>
<ArticleTitle>Biodistribution, pharmacokinetics, and nuclear imaging studies of 111In-labeled rGel/BLyS fusion toxin in SCID mice bearing B cell lymphoma.</ArticleTitle>
<Pagination><MedlinePgn>721-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s11307-010-0391-0</ELocationID>
<Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">We examined the biodistribution and pharmacokinetics of (111)In-labeled rGel/BLyS, a gelonin toxin (rGel)-B lymphocyte stimulator (BLyS) fusion protein.</AbstractText>
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">rGel/BLyS was labeled with In-111 through DTPA with a labeling efficiency >95%. Biodistribution/imaging studies were obtained in severe-combined immunodeficiency mice bearing diffuse large B cell lymphoma OCI-Ly10. Pharmacokinetic studies were performed in BALB/c mice.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In vitro, DTPA-conjugated rGel/BLyS displayed selective cytotoxicity against OCI-Ly10 cells and mantle cell lymphoma JeKo cells. In vivo, rGel/BLyS exhibited a tri-exponential disposition with a rapid initial mean distribution followed by an extensive mean distribution and a long terminal elimination phase. At 48 h after injection, uptake of the radiotracer in tumors was 1.25 %ID/g, with a tumor-to-blood ratio of 13. Tumors were clearly visualized at 24-72 h post-injection. Micro-SPECT-CT images and ex vivo analyses confirmed the accumulation of rGel/BLyS in OCI-Ly10 tumors.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">(111)In-DTPA-rGel/BLyS are distributed to B cell tumors and induce apoptosis in tumors. Preclinical antitumor studies using rGel/BLyS should use a twice-per-week treatment schedule.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wen</LastName>
<ForeName>Xiaoxia</ForeName>
<Initials>X</Initials>
<Affiliation>Department of Experimental Diagnostic Imaging, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
</Author>
<Author ValidYN="Y"><LastName>Lyu</LastName>
<ForeName>Mi-Ae</ForeName>
<Initials>MA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Zhang</LastName>
<ForeName>Rui</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lu</LastName>
<ForeName>Wei</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y"><LastName>Huang</LastName>
<ForeName>Qian</ForeName>
<Initials>Q</Initials>
</Author>
<Author ValidYN="Y"><LastName>Liang</LastName>
<ForeName>Dong</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Rosenblum</LastName>
<ForeName>Michael G</ForeName>
<Initials>MG</Initials>
</Author>
<Author ValidYN="Y"><LastName>Li</LastName>
<ForeName>Chun</ForeName>
<Initials>C</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>CA016672</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType>Journal Article</PublicationType>
<PublicationType>Research Support, N.I.H., Extramural</PublicationType>
<PublicationType>Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mol Imaging Biol</MedlineTA>
<NlmUniqueID>101125610</NlmUniqueID>
<ISSNLinking>1536-1632</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance>B-Cell Activating Factor</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Indium Radioisotopes</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Recombinant Fusion Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance>Ribosome Inactivating Proteins, Type 1</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>75037-46-6</RegistryNumber>
<NameOfSubstance>GEL protein, Gelonium multiflorum</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>7A314HQM0I</RegistryNumber>
<NameOfSubstance>Pentetic Acid</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">B-Cell Activating Factor</DescriptorName>
<QualifierName MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName MajorTopicYN="N">blood</QualifierName>
<QualifierName MajorTopicYN="Y">pharmacokinetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Cell Death</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Chromatography, Thin Layer</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Indium Radioisotopes</DescriptorName>
<QualifierName MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName MajorTopicYN="N">blood</QualifierName>
<QualifierName MajorTopicYN="Y">pharmacokinetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Injections, Intravenous</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Lymphoma, B-Cell</DescriptorName>
<QualifierName MajorTopicYN="N">blood</QualifierName>
<QualifierName MajorTopicYN="N">pathology</QualifierName>
<QualifierName MajorTopicYN="N">radiography</QualifierName>
<QualifierName MajorTopicYN="Y">radionuclide imaging</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Mice, SCID</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Pentetic Acid</DescriptorName>
<QualifierName MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName>
<QualifierName MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName MajorTopicYN="N">blood</QualifierName>
<QualifierName MajorTopicYN="Y">pharmacokinetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Ribosome Inactivating Proteins, Type 1</DescriptorName>
<QualifierName MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName MajorTopicYN="N">blood</QualifierName>
<QualifierName MajorTopicYN="Y">pharmacokinetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Staining and Labeling</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N">Tissue Distribution</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y">Tomography, Emission-Computed, Single-Photon</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y">Tomography, X-Ray Computed</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year>
<Month>8</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2010</Year>
<Month>8</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2011</Year>
<Month>10</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1007/s11307-010-0391-0</ArticleId>
<ArticleId IdType="pubmed">20686856</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=IndiumV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001580 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001580 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= *** parameter Area/wikiCode missing *** |area= IndiumV2 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:20686856 |texte= Biodistribution, pharmacokinetics, and nuclear imaging studies of 111In-labeled rGel/BLyS fusion toxin in SCID mice bearing B cell lymphoma. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:20686856" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a IndiumV2
This area was generated with Dilib version V0.5.76. |